Open Journal Of Apoptosis
agents/materials/analysis tools: NCM CRC 23388095 23388095 KGS LF SS MicroRNAs in LVH DS MAC MEA AB NC UM LER. Wrote the paper: NCM AB NC UM LER. References 1. Dorn GW 2nd The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49: 962970. 2. Pluim BM, Zwinderman AH, van der Laarse A, van der Wall EE The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 101: 336344. three. Barauna VG, Magalhaes FC, Krieger JE, Oliveira EM AT1 receptor participates inside the cardiac hypertrophy induced by resistance training in rats. Am J Physiol Regul Integr Comp Physiol 295: R381387. 4. Oliveira EM, Sasaki MS, Cerencio M, Barauna VG, Krieger JE Nearby renin-angiotensin program regulates left ventricular hypertrophy induced by swimming instruction independent of circulating renin: a pharmacological study. J Renin Angiotensin Aldosterone Syst 10: 1523. 5. Oliveira RS, Ferreira JC, Gomes ER, Paixao NA, Rolim NP, et al. Cardiac anti-remodelling impact of aerobic training is connected with a reduction within the calcineurin/NFAT signalling pathway in heart failure mice. J Physiol 587: 38993910. 6. Bartel DP MicroRNAs: target recognition and regulatory functions. Cell 136: 215233. 7. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735739. eight. Cheng Y, Zhu P, Yang J, Liu X, Dong S, et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury by means of anti-apoptosis by way of its target PDCD4. Cardiovasc Res 87: 431 439. 9. Fukushima Y, Nakanishi M, Nonogi H, Goto Y, Iwai N Assessment of plasma miRNAs in congestive heart failure. Circ J 75: 336340. ten. Small EM, Olson EN Pervasive roles of microRNAs in cardiovascular biology. Nature 469: 336342. 11. Jentzsch C, Leierseder S, Loyer X, Flohrschutz I, Sassi Y, et al. A phenotypic screen to recognize hypertrophy-modulating microRNAs in principal cardiomyocytes. J Mol Cell Cardiol 52: 1320. 12. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, et al. A signature pattern of stress-responsive microRNAs which will evoke cardiac hypertrophy and heart failure. PNAS, USA 103: 1825518260. 13. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, et al. Manage of stress-dependent cardiac development and gene expression by a microRNA. Science 316: 575579. 14. Fernandes T, Hashimoto NY, Magalhaes FC, Fernandes FB, Casarini DE, et al. Aerobic workout training-induced left ventricular hypertrophy includes regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin. Hypertension 58: 182189. 15. LaPier TL, Swislocki AL, Clark RJ, Rodnick KJ Voluntary operating improves glucose tolerance and insulin resistance in female spontaneously hypertensive rats. Am J Hypertens 14: 708715. 16. Natali AJ, Turner DL, Harrison SM, White E Regional effects of voluntary exercise on cell size and contraction-frequency responses in rat cardiac myocytes. J Exp Biol 204: 11911199. 17. Foppa M, Duncan BB, Rohde LE Echocardiography-based left ventricular mass estimation. How should MC 903 really we define hypertrophy Cardiovascular Ultrasound 3: 17. 18. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A Evaluation of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833840. 19. Sourvinou IS, Markou A, Lianidou ES Quantification of Circulating miRNAs in Plasma: Effect of Preanalytical and Analytical Para
